2019JAMA Internal MedicineOpen access

Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available

Mariana P. Socal, Ge Bai, Gerard F. Anderson

Open full text 28 citations

Abstract

This study examines Medicare Part D prescription drug plans to assess how often branded products were given more favorable formulary placement than generic products.

Open-access reader

About this research paper

What this paper is about

This study examines Medicare Part D prescription drug plans to assess how often branded products were given more favorable formulary placement than generic products.

Why it matters

OpenAlex reports 28 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This study examines Medicare Part D prescription drug plans to assess how often branded products were given more favorable formulary placement than generic products.

Key concepts: Formulary, Medicine, Medical prescription, Prescription drug, Medicare Part D, Drug, Family medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available — Research Paper | ScholarLens